Eicosanoids, the metabolic products of arachidonic acid, are potent mediators of various components of inflammation, including increased sensitivity to noxious stimuli. Although the mechanisms by which eicosanoids cause inflammation remain unknown, evidence suggests that they activate or facilitate activation of small diameter sensory neurons. This activation and the subsequent release of neuropeptides from these neurons results in neurogenic inflammation and enhanced pain sensation. The studies outlined in this proposal will examine the effects of various eicosanoids on the initiation of neurogenic inflammation by measuring their ability to alter the resting or stimulated release of the neuropeptides, substance P (SP) and calcitonin gene-related peptide (CGRP) from sensory neurons. Studies also will attempt to elucidate the cellular mechanisms of eicosanoid actions by determining cause-effect relationships between changes in peptide release and second messenger systems. Regulation of peptide release by eicosanoids will be studied using two experimental models, in vitro release from spinal cord slices and release from rat sensory neurons grown in culture. The former model allows examination of eicosanoid effects at the level of sensory input to the spinal cord, whereas the latter affords the opportunity to study the cellular mechanisms of eicosanoid actions on isolated sensory neurons. Neuronal tissues will be exposed to eicosanoids and the amount of SP and CGRP released from these preparations measured by radioimmunoassay. To assess the sensitization of sensory neurons, release evoked by various chemical stimuli will be determined in the presence an absence of eicosanoids. Using sensory neurons in culture, second messenger concentrations in cells will be measured in the presence and absence of sensitizing concentrations of eicosanoids. Intracellular content of second messengers will be altered to determine if these manipulations attenuate or potentiate eicosanoid effects on peptide release. In this manner, we can determine which signal transduction pathways mediate eicosanoid effects on peptide release from sensory neurons. Finally, we will determine if the eicosanoid-induced alterations in peptide release correlate with an changes in the phosphorylation of neuronal proteins from isolated sensory neurons. These studies will provide basic information as to the mechanisms of eicosanoid actions on sensor neurons. Furthermore, experiments will establish whether eicosanoid actions at the level of the spina cord are important in altering neuronal sensitivity during inflammation. This knowledge is critically important for understanding the process of neurogenic inflammation and in ultimately designing new drug therapies for the management of inflammatory diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS034159-03
Application #
2416389
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Program Officer
Kitt, Cheryl A
Project Start
1995-05-01
Project End
1999-04-30
Budget Start
1997-05-01
Budget End
1998-04-30
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Pharmacology
Type
Schools of Medicine
DUNS #
005436803
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Malty, Ramy Habashy; Hudmon, Andy; Fehrenbacher, Jill C et al. (2016) Long-term exposure to PGE2 causes homologous desensitization of receptor-mediated activation of protein kinase A. J Neuroinflammation 13:181
Shariati, Behzad; Thompson, Eric L; Nicol, Grant D et al. (2016) Epac activation sensitizes rat sensory neurons through activation of Ras. Mol Cell Neurosci 70:54-67
Vasko, Michael R; Guo, Chunlu; Kelley, Mark R (2005) The multifunctional DNA repair/redox enzyme Ape1/Ref-1 promotes survival of neurons after oxidative stress. DNA Repair (Amst) 4:367-79
Fehrenbacher, Jill C; Burkey, Thomas H; Nicol, Grant D et al. (2005) Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells. Pain 113:113-22
Fehrenbacher, Jill C; Taylor, Charles P; Vasko, Michael R (2003) Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain 105:133-41
Huang, H; Wu, X; Nicol, G D et al. (2003) ATP augments peptide release from rat sensory neurons in culture through activation of P2Y receptors. J Pharmacol Exp Ther 306:1137-44
Wang, XiaoXia; Butowt, Rafal; Vasko, Michael R et al. (2002) Mechanisms of the release of anterogradely transported neurotrophin-3 from axon terminals. J Neurosci 22:931-45
Southall, M D; Bolyard, L A; Vasko, M R (2002) Twenty-four hour exposure to prostaglandin downregulates prostanoid receptor binding but does not alter PGE(2)-mediated sensitization of rat sensory neurons. Pain 96:285-96
Richardson, Jennelle Durnett; Vasko, Michael R (2002) Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther 302:839-45
Southall, M D; Vasko, M R (2001) Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons. J Biol Chem 276:16083-91

Showing the most recent 10 out of 20 publications